CytomX Therapeutics Inc. (CTMX)

AI Score

Unlock

0.47

-0.07 (-13.46%)

At close: Apr 04, 2025, 10:56 AM

CytomX Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Cash & Equivalents	38.05M	17.17M	193.65M	205.53M	191.86M	188.43M	247.58M	177.55M	104.64M	59.82M	64.4M	8.7M
Short-Term Investments	62.57M	157.34M	n/a	99.7M	124.26M	107.72M	188.55M	196.56M	77.29M	126.89M	n/a	n/a
Long-Term Investments	n/a	n/a	917K	917K	917K	917K	917K	917K	917K	995K	n/a	n/a
Other Long-Term Assets	1.09M	1M	-3.57M	-3.71M	-3.37M	2.93M	238K	957K	2.66M	-115K	492K	148K
Receivables	3.1M	3.43M	35.99M	790K	798K	13K	97K	10.14M	2.31M	744K	1.88M	237K
Inventory	n/a	n/a	n/a	1.00	1.00	1.00	n/a	1.00	1.00	1.00	100K	100K
Other Current Assets	3.58M	5M	7.47M	4.29M	7.1M	7.18M	9.25M	4.35M	n/a	2.3M	100K	100K
Total Current Assets	107.31M	182.94M	237.1M	310.3M	324.01M	303.33M	445.48M	388.6M	188.15M	189.75M	66.85M	9.27M
Property-Plant & Equipment	10.6M	16.18M	21.02M	25.32M	29.45M	32.75M	6.93M	4.22M	4.39M	3.48M	3.02M	2.07M
Goodwill & Intangibles	1.53M	1.68M	1.82M	1.97M	2.12M	2.26M	2.41M	2.55M	2.7M	2.7M	2.7M	2.7M
Total Long-Term Assets	13.23M	18.86M	23.79M	29.11M	34.65M	37.95M	11.63M	9.04M	10.98M	7.46M	6.21M	4.92M
Total Assets	120.53M	201.79M	260.89M	339.41M	358.66M	341.28M	457.11M	397.64M	199.13M	197.22M	73.06M	14.18M
Account Payables	1.09M	1.46M	2.81M	2.82M	3M	4.16M	5.13M	4.21M	6.6M	4.7M	1.92M	930K
Deferred Revenue	67.2M	132.27M	121.27M	69.26M	74.87M	51.38M	52.71M	40.56M	20.35M	6.13M	6.13M	857K
Short-Term Debt	5.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.42M	1.26M
Other Current Liabilities	12.34M	9.44M	16.39M	21.04M	11.5M	20.52M	20.14M	11.86M	4.85M	2.07M	836K	405K
Total Current Liabilities	85.77M	155.91M	152.61M	106.32M	100.92M	85.59M	97.91M	61.15M	35.77M	15.74M	11.16M	4.17M
Long-Term Debt	4.24M	n/a	13.97M	18.06M	21.68M	24.87M	n/a	n/a	n/a	n/a	1.57M	2.94M
Other Long-Term Liabilities	30.98M	3.89M	-13.97M	100.23M	-21.68M	-24.02M	3.05M	1.9M	566K	198K	77.54M	46.21M
Total Long-Term Liabilities	35.22M	93.33M	194.03M	143.72M	207.94M	204.58M	228.32M	266.6M	84.88M	55.41M	140.44M	54.29M
Total Liabilities	120.99M	249.24M	346.64M	250.03M	308.86M	290.17M	326.23M	327.75M	120.65M	71.15M	151.6M	58.46M
Total Debt	9.38M	13.97M	18.06M	18.06M	24.87M	24.87M	n/a	n/a	n/a	n/a	2.99M	4.2M
Common Stock	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-691.58M	-723.45M	-722.88M	-533.72M	-450.12M	-417.23M	-314.98M	-219.47M	-176.37M	-117.47M	-78.14M	-43.88M
Comprehensive Income	27K	95K	10K	-242K	-47K	57K	-93K	-94K	-27K	-76K	-404K	-399K
Shareholders Equity	-456K	-47.45M	-85.75M	89.38M	49.8M	51.11M	130.88M	69.9M	78.48M	126.07M	-78.54M	-44.28M
Total Investments	62.57M	157.34M	917K	99.7M	124.26M	107.72M	188.55M	196.56M	77.29M	126.89M	n/a	n/a